ORIGINAL RESEARCH
Accepted on 18 Jul 2025
Cadonilimab in combination with chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: A cost-effectiveness analysis
doi 10.3389/fphar.2025.1646818
- Frontiers in Pharmacology
- Translational Pharmacology
- Research Topics
- Emerging Targeted and Immunotherapeutic Strategies in Oncology: From Solid Tumors to Hematologic Malignancies
Emerging Targeted and Immunotherapeutic Strategies in Oncology: From Solid Tumors to Hematologic Malignancies
483
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.